COVID-19-Related Intracerebral Hemorrhage
Внутримозговое кровоизлияние, связанное с COVID-19
2020-10-22
SCID: 54.1/zg8ubcqt
Discuss with AI
COVID-19angiotensin-converting enzyme 2 (ACE2)hemorrhagic strokeintracerebral hemorrhageoveractive immune response
Figures from the paper
Abstract (AI)
Intracerebral hemorrhage (ICH) is a common and severe neurological disorder and is associated with high rates of mortality and morbidity. ICH is associated with old age and underlying conditions such as hypertension and diabetes mellitus. The COVID-19 pandemic is associated with neurological symptoms and complications including ICH. For instance, the mechanisms by which COVID-19 may contribute to hemorrhagic stroke may include both depletion of angiotensin converting enzyme 2 (ACE2) receptor and overactive immune response. In this study, we herein report three patients (0.25%) out of 1200 admissions with COVID-19 to our center between 1 May and August 4, 2020, who developed ICH. In addition, we will briefly discuss the possible pathophysiological mechanisms of COVID-19 infection in patients with ICH.
Key Findings
1
Intracerebral hemorrhage occurred in three of 1,200 patients admitted with COVID-19, corresponding to an incidence of 0.25%.
2
Potential mechanisms linking COVID-19 to hemorrhagic stroke include depletion of ACE2 receptors and an overactive immune response.
3
The paper emphasizes that ICH commonly carries high mortality and morbidity and is associated with older age, hypertension, and diabetes mellitus.
4
The report identifies ICH as a neurological complication observed during COVID-19 infection.
Research Object
COVID-19 patients who developed intracerebral hemorrhage
Research Subject
The occurrence and possible pathophysiological mechanisms of intracerebral hemorrhage associated with COVID-19
Publication Details
Publication Date
2020-10-22
Journal
Publisher
ISSN
Cited by
51
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest